Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.
about
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@en
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@nl
type
label
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@en
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@nl
prefLabel
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@en
Intralymphatic Glutamic Acid D ...... ical Trial in Type 1 Diabetes.
@nl
P2093
P2860
P50
P356
P1476
Intralymphatic Glutamic Acid D ...... nical Trial in Type 1 Diabetes
@en
P2093
Jeannette Wahlberg
Johnny Ludvigsson
Peter Achenbach
P2860
P304
P356
10.1155/2018/9391845
P577
2018-05-24T00:00:00Z